Literature DB >> 17070050

Dysferlin expression in monocytes: a source of mRNA for mutation analysis.

N De Luna1, A Freixas, P Gallano, L Caselles, R Rojas-García, C Paradas, G Nogales, R Dominguez-Perles, L Gonzalez-Quereda, J J Vílchez, C Márquez, J Bautista, A Guerrero, J A Salazar, A Pou, I Illa, E Gallardo.   

Abstract

Dysferlin protein is expressed in peripheral blood monocytes. The genomic analysis of the DYSF gene has proved to be time consuming because it has 55 exons. We designed a mutational screening strategy based on cDNA from monocytes to find out whether the mutational analysis could be performed in mRNA from a source less invasive than the muscle biopsy. We studied 34 patients from 23 families diagnosed with dysferlinopathy. The diagnosis was based on clinical findings and on the absence of protein expression using either immunohistochemistry or Western blot of skeletal muscle and/or monocytes. We identified 28 different mutations, 13 of which were novel. The DYSF mutations in both alleles were found in 30 patients and only in one allele in four. The results were confirmed using genomic DNA in 26/34 patients. This is the first report to furnish evidence of reliable mutational analysis using monocytes cDNA and constitutes a good alternative to genomic DNA analysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070050     DOI: 10.1016/j.nmd.2006.09.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  27 in total

1.  Identification and characterisation of human dysferlin transcript variants: implications for dysferlin mutational screening and isoforms.

Authors:  Zacharias Aloysius Dwi Pramono; Chin Lai Tan; Irene Ai Lian Seah; Joseph Shean Long See; Siok Yuen Kam; Poh San Lai; Woon Chee Yee
Journal:  Hum Genet       Date:  2009-02-17       Impact factor: 4.132

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules.

Authors:  Bilal A Azakir; Sabrina Di Fulvio; Steven Salomon; Marielle Brockhoff; Christian Therrien; Michael Sinnreich
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

4.  Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.

Authors:  L Blázquez; M Azpitarte; A Sáenz; M Goicoechea; D Otaegui; X Ferrer; I Illa; E Gutierrez-Rivas; J J Vilchez; A López de Munain
Journal:  Neurogenetics       Date:  2008-06-19       Impact factor: 2.660

5.  Quantitation of the calcium and membrane binding properties of the C2 domains of dysferlin.

Authors:  Nazish Abdullah; Murugesh Padmanarayana; Naomi J Marty; Colin P Johnson
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

6.  Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.

Authors:  Douglas P Millay; Marjorie Maillet; Joseph A Roche; Michelle A Sargent; Elizabeth M McNally; Robert J Bloch; Jeffery D Molkentin
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

7.  Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype.

Authors:  Sree Rayavarapu; Jack H Van der Meulen; Heather Gordish-Dressman; Eric P Hoffman; Kanneboyina Nagaraju; Susan M Knoblach
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

8.  Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.

Authors:  Kanneboyina Nagaraju; Rashmi Rawat; Edina Veszelovszky; Rachana Thapliyal; Akanchha Kesari; Susan Sparks; Nina Raben; Paul Plotz; Eric P Hoffman
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

9.  Bone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement.

Authors:  Bàrbara Flix; Xavier Suárez-Calvet; Jordi Díaz-Manera; Eva Santos-Nogueira; Renzo Mancuso; Jordi Barquinero; Miquel Navas; Xavier Navarro; Isabel Illa; Eduard Gallardo
Journal:  Stem Cells Dev       Date:  2013-07-26       Impact factor: 3.272

10.  Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.

Authors:  Yen-Hui Chiu; Mark A Hornsey; Lars Klinge; Louise H Jørgensen; Steven H Laval; Richard Charlton; Rita Barresi; Volker Straub; Hanns Lochmüller; Kate Bushby
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.